IPP Bureau
FDA accepts supplemental Biologics License Application for Roche’s Columvi combination
By IPP Bureau - December 06, 2024
For people with relapsed or refractory diffuse large B-cell lymphoma
Lupin’s R&D facility in Pune bags LEED Platinum Certification
By IPP Bureau - December 06, 2024
Reaffirms Lupin’s commitment to sustainable resource management
Eugia Pharma receives USFDA approval for Pazopanib Tablets, 200 mg
By IPP Bureau - December 06, 2024
The approved product has an estimated market size of US$ 106 million for the twelve months ending October 2024, according to IQVIA
Torrent Pharma inks agreement with Boehringer Ingelheim to acquire 3 anti-diabetes brands
By IPP Bureau - December 05, 2024
The acquisition further strengthens Torrent’s existing diabetes care portfolio and its presence in the Oral Anti Diabetic market
Granules India update on USFDA inspection at Gagillapur facility
By IPP Bureau - December 05, 2024
Granules has undertaken a proactive, voluntary and comprehensive remediation plan to address the six form 483 observations raised by the USFDA
Alembic Pharmaceuticals gets USFDA tentative approval for OTC
By IPP Bureau - December 05, 2024
Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC) is used to temporarily relieve itchy eyes due to pollen, ragweed, grass, animal hair and dander
Lupin gets tentative approval from USFDA for Sitagliptin and Metformin Hydrochloride Tablets
By IPP Bureau - December 05, 2024
Sitagliptin and Metformin Hydrochloride Tablets, 50 mg/500 mg and 50 mg/1000 mg are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
Aster and Blackstone-backed Quality Care to merge and create hospital chains in India
By IPP Bureau - December 04, 2024
Aster DM Healthcare and Quality Care India Limited have signed definitive agreements to merge, subject to regulatory, corporate and shareholders’ approvals
Biocon celebrates 46th Founder’s Day
By IPP Bureau - December 04, 2024
The celebrations began with the unveiling of the Biocon Anthem
Ann-Xiaoyan Li appointed Group CFO and MD of Romaco Group
By IPP Bureau - December 04, 2024
She will be responsible in this role for Finance & Controlling, HR Services and IT Management at Romaco Holding
Gland Pharma receives approval for Latanoprost Opthalmic Solution, 0.005%
By IPP Bureau - December 04, 2024
The Product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Xalatan
Dr. Reddy's launches Toripalimab in India
By IPP Bureau - December 01, 2024
The first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma
Aster DM Healthcare to acquire the balance stake in Aster Aadhar Hospital
By IPP Bureau - November 28, 2024
The 254-bedded Aster Aadhar Hospital, Kolhapur is the city's most comprehensive multi-speciality hospital
Glenmark Pharmaceuticals USA launches Travoprost Ophthalmic Solution USP, 0.004%
By IPP Bureau - November 28, 2024
Glenmark's Travoprost Ophthalmic Solution USP, 0.004% is bioequivalent and therapeutically equivalent to the reference listed drug, Travatan Z Ophthalmic Solution USP, 0.004% of Sandoz
